XueJun Liu

Company: I-MAB Biopharma Co., Ltd.

Job title: Executive director, Translational Medicine

Seminars:

Panel Discussion: Insights into Claudin Biology & its Impact On Cancer Progression 9:30 am

Understanding the dynamic expression patterns of Claudin 18.2, 6, and 9 in different cancer stages and the implications for therapeutic targeting Outlining the role of claudin proteins in tumor microenvironment interactions and how these interactions influence cancer progression and metastasis Identifying how understanding claudin biology can inform clinical strategies and improve therapeutic outcomes, including the…Read more

day: Conference Day 2